ProfileGDS4459 / ENSG00000197915
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 2% 1% 8% 33% 10% 15% 29% 36% 15% 15% 12% 17% 16% 38% 8% 25% 18% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 12.22
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 22.041
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 32.148
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 43.9433
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 52.4610
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 62.9815
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 73.5229
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 83.7936
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 92.6915
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 102.7715
GSM623474group B, liver allograft wedge biopsie placebo treatment 12.7412
GSM623475group B, liver allograft wedge biopsie placebo treatment 22.7717
GSM623476group B, liver allograft wedge biopsie placebo treatment 32.8316
GSM623477group B, liver allograft wedge biopsie placebo treatment 44.0538
GSM623478group B, liver allograft wedge biopsie placebo treatment 52.118
GSM623479group B, liver allograft wedge biopsie placebo treatment 63.5825
GSM623480group B, liver allograft wedge biopsie placebo treatment 73.2618